إعلان
إعلان
KRYS
Krystal Biotech, Inc. Common Stock
246.49
USDبرعاية
-0.05
-0.02%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
246.50
+0.01
0.00%
تقارير أرباح KRYS
النسبة الإيجابية المفاجئة
KRYS تفوق 18 من 33 آخر التقديرات.
55%
التقرير التالي
بيانات التقرير القادم
١٧ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$107.54M
/$1.29
التغير الضمني من Q3 25 (Revenue/ EPS)
+9.96%
/-51.50%
التغير الضمني من Q4 24 (Revenue/ EPS)
+18.00%
/-15.13%
Krystal Biotech, Inc. Common Stock earnings per share and revenue
On ٠٣ نوفمبر ٢٠٢٥, KRYS reported earnings of 2.66 USD per share (EPS) for Q3 25, beating the estimate of 1.10 USD, resulting in a 140.22% surprise. Revenue reached 97.80 مليون, compared to an expected 95.05 مليون, with a 2.89% difference. The market reacted with a +0.17% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analysts forecast an EPS of 1.29 USD, with revenue projected to reach 107.54 مليون USD, implying an decrease of -51.50% EPS, and increase of 9.96% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
١٩ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.25
الفعلي
-$0.19
مفاجئة
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were Krystal Biotech, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Krystal Biotech, Inc. Common Stock reported EPS of $2.66, beating estimates by 140.22%, and revenue of $97.80M, 2.89% above expectations.
How did the market react to Krystal Biotech, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 0.17%, changed from $197.51 before the earnings release to $197.85 the day after.
When is Krystal Biotech, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٧ فبراير ٢٠٢٦.
What are the forecasts for Krystal Biotech, Inc. Common Stock's next earnings report?
Based on 12
analysts, Krystal Biotech, Inc. Common Stock is expected to report EPS of $1.29 and revenue of $107.54M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان